Literature DB >> 24136748

Variance of TNFAIP8 expression between tumor tissues and tumor-infiltrating CD4+ and CD8+ T cells in non-small cell lung cancer.

Lingcheng Wang1, Yinghua Song, Xuelin Men.   

Abstract

Tumor necrosis factor alpha-induced protein 8 (TNFAIP8) has been recently documented in various malignancies, but its role in non-small cell lung cancer (NSCLC) remains uncertain. In the current study, we investigated the level of TNFAIP8 in NSCLC tissues, adjacent noncancerous lung tissues, healthy lung tissues, CD4+ T cells, and CD8+ T cells by real-time reverse transcription PCR (RT-PCR) and Western blot analysis. Results revealed that the mRNA level of TNFAIP8 was significantly increased in cancer tissue than in healthy lung tissue from donors (p < 0.001). Interestingly, adjacent noncancerous lung tissues also showed higher mRNA level of TNFAIP8 than healthy lung tissue from donors (p < 0.01). Similarly, protein level of TNFAIP8 was elevated in NSCLC tissues and adjacent noncancerous lung tissues. We further analyzed TNFAIP8 expression in CD4+ T cells and CD8+ T cells. Data demonstrated that both mRNA level and protein level were significantly decreased in tumor-infiltrating CD4+ and CD8+ T cells than in peripheral CD4+ and CD8+ T cells. Moreover, patients with advanced stages presented lower protein expression of TNFAIP8 in tumor-infiltrating CD8+ T cells than patients with primary stages (p < 0.05). These results provide evidence that TNFAIP8 plays critical roles in NSCLC and may be used as a therapeutic target for the disease.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24136748     DOI: 10.1007/s13277-013-1307-9

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  23 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  A different TIPE of immune homeostasis.

Authors:  Eric C Freundt; Nicolas Bidere; Michael J Lenardo
Journal:  Cell       Date:  2008-05-02       Impact factor: 41.582

3.  Identification of a novel tumor necrosis factor-alpha-inducible gene, SCC-S2, containing the consensus sequence of a death effector domain of fas-associated death domain-like interleukin- 1beta-converting enzyme-inhibitory protein.

Authors:  D Kumar; T L Whiteside; U Kasid
Journal:  J Biol Chem       Date:  2000-01-28       Impact factor: 5.157

4.  Functional variants in TNFAIP8 associated with cervical cancer susceptibility and clinical outcomes.

Authors:  Ting-Yan Shi; Xi Cheng; Ke-Da Yu; Meng-Hong Sun; Zhi-Ming Shao; Meng-Yun Wang; Mei-Ling Zhu; Jing He; Qiao-Xin Li; Xiao-Jun Chen; Xiao-Yan Zhou; Xiaohua Wu; Qingyi Wei
Journal:  Carcinogenesis       Date:  2013-01-08       Impact factor: 4.944

5.  Expression of tumor necrosis factor-alpha-induced protein 8 in pancreas tissues and its correlation with epithelial growth factor receptor levels.

Authors:  Ke Liu; Cheng-Kun Qin; Zhi-Yi Wang; Su-Xia Liu; Xian-Ping Cui; Dong-Yuan Zhang
Journal:  Asian Pac J Cancer Prev       Date:  2012

6.  Nuclear factor-kappa B-inducible death effector domain-containing protein suppresses tumor necrosis factor-mediated apoptosis by inhibiting caspase-8 activity.

Authors:  Z You; H Ouyang; D Lopatin; P J Polver; C Y Wang
Journal:  J Biol Chem       Date:  2001-05-09       Impact factor: 5.157

7.  Expression and regulation of a novel identified TNFAIP8 family is associated with diabetic nephropathy.

Authors:  Shuya Zhang; Yan Zhang; Xinbing Wei; Junhui Zhen; Ziying Wang; Minyong Li; Wei Miao; Hua Ding; Pengchao Du; Wenchao Zhang; Min He; Fan Yi
Journal:  Biochim Biophys Acta       Date:  2010-08-08

8.  TIPE2, a negative regulator of innate and adaptive immunity that maintains immune homeostasis.

Authors:  Honghong Sun; Shunyou Gong; Ruaidhri J Carmody; Anja Hilliard; Li Li; Jing Sun; Li Kong; Lingyun Xu; Brendan Hilliard; Shimin Hu; Hao Shen; Xiaolu Yang; Youhai H Chen
Journal:  Cell       Date:  2008-05-02       Impact factor: 41.582

9.  SCC-S2 is overexpressed in colon cancers and regulates cell proliferation.

Authors:  Zhifeng Miao; Tingting Zhao; Zhenning Wang; Yingying Xu; Yongxi Song; Jianhua Wu; Huimian Xu
Journal:  Tumour Biol       Date:  2012-08-12

10.  The significance of TNFAIP8 in prostate cancer response to radiation and docetaxel and disease recurrence.

Authors:  Chuanbo Zhang; Bhaskar V Kallakury; Jeffrey S Ross; Rajshree R Mewani; Christine E Sheehan; Isamu Sakabe; George Luta; Deepak Kumar; Sivaramakrishna Yadavalli; Joshua Starr; Taduru L Sreenath; Shiv Srivastava; Harvey B Pollard; Ofer Eidelman; Meera Srivastava; Usha N Kasid
Journal:  Int J Cancer       Date:  2013-01-10       Impact factor: 7.396

View more
  18 in total

1.  SCC-S2 Facilitates Tumor Proliferation and Invasion via Activating Wnt Signaling and Depressing Hippo Signaling in Colorectal Cancer Cells and Predicts Poor Prognosis of Patients.

Authors:  Chuanjia Yang; Weixue Xu; Xiangzhen Meng; Siqi Zhou; Minglu Zhang; Dongxu Cui
Journal:  J Histochem Cytochem       Date:  2018-09-14       Impact factor: 2.479

2.  CD8+ cytotoxic and FoxP3+ regulatory T lymphocytes serve as prognostic factors in breast cancer.

Authors:  Gong-Ling Peng; Liang Li; Ya-Wen Guo; Pan Yu; Xing-Jie Yin; Shan Wang; Chun-Ping Liu
Journal:  Am J Transl Res       Date:  2019-08-15       Impact factor: 4.060

Review 3.  Regulation of inflammation and tumorigenesis by the TIPE family of phospholipid transfer proteins.

Authors:  Jason R Goldsmith; Svetlana Fayngerts; Youhai H Chen
Journal:  Cell Mol Immunol       Date:  2017-03-13       Impact factor: 11.530

Review 4.  The paradoxical role of tumor-infiltrating immune cells in lung cancer.

Authors:  Xiaodan Zheng; Yuhai Hu; Chengfang Yao
Journal:  Intractable Rare Dis Res       Date:  2017-11

5.  Upregulation of SCC-S2 in immune cells and tumor tissues of papillary thyroid carcinoma.

Authors:  Dong Duan; Yu-Quan Zhu; Li-Li Guan; Jie Wang
Journal:  Tumour Biol       Date:  2014-01-24

6.  A rare DNA contact mutation in cancer confers p53 gain-of-function and tumor cell survival via TNFAIP8 induction.

Authors:  Jessica A Monteith; Hestia Mellert; Morgan A Sammons; Laudita A Kuswanto; Stephen M Sykes; Lois Resnick-Silverman; James J Manfredi; Shelley L Berger; Steven B McMahon
Journal:  Mol Oncol       Date:  2016-06-07       Impact factor: 6.603

7.  In Silico Analysis of Tumor Necrosis Factor α-Induced Protein 8-Like-1 (TIPE1) Protein.

Authors:  Pei Shen; Hong Zhang; Zhaoliang Su; Shengjun Wang; Huaxi Xu
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

8.  TNFAIP8 interacts with LATS1 and promotes aggressiveness through regulation of Hippo pathway in hepatocellular carcinoma.

Authors:  Qianze Dong; Lin Fu; Yue Zhao; Chengyao Xie; Qingchang Li; Enhua Wang
Journal:  Oncotarget       Date:  2017-02-28

Review 9.  Tumor Necrosis Factor-α Induced Protein 8: Pathophysiology, Clinical Significance, and Regulatory Mechanism.

Authors:  Lei Zhang; Ran Liu; Ying-Yi Luan; Yong-Ming Yao
Journal:  Int J Biol Sci       Date:  2018-03-10       Impact factor: 6.580

10.  TIPE1 function as a prognosis predictor and negative regulator of lung cancer.

Authors:  Xiaocheng Wu; Yunmiao Ma; Ji Cheng; Xia Li; Hui Zheng; Li Jiang; Renjie Zhou
Journal:  Oncotarget       Date:  2017-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.